Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zura Bio

1.28
+0.200018.52%
Post-market: 1.300.0200+1.56%18:28 EDT
Volume:389.07K
Turnover:473.73K
Market Cap:83.58M
PE:-1.93
High:1.28
Open:1.10
Low:1.10
Close:1.08
Loading ...

Company Profile

Company Name:
Zura Bio
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
15
Office Location:
1489 W. Warm Springs Road,Suite 110,Henderson,Nevada,United States
Zip Code:
89014
Fax:
- -
Introduction:
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.

Directors

Name
Position
Someit Sidhu
Chairman and Chief Executive Officer
Tauhid Ali
Chief Operating Officer and Director
Arnout Ploos van Amstel
Director
Graeme Sloan
Director
Javier Cote Sierra
Director
Josh Distler
Director

Shareholders

Name
Position
Someit Sidhu
Chairman and Chief Executive Officer
Tauhid Ali
Chief Operating Officer and Director
Verender S. Badial
Chief Financial Officer
Yuan Hua Ding
Advisor